CC
ABVX

Commodore Capital’s Abivax ABVX Stock Holding History

Commodore Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,284,110
Closed -$9.4M – 32
2024
Q4 		$9.4M Hold
1,284,110
– – 0.69% 24
2024
Q3 		$14.8M Hold
1,284,110
– – 0.92% 29
2024
Q2 		$17M Sell
1,284,110
-610,893
-32% -$8.74M 1.16% 23
2024
Q1 		$27.1M Hold
1,895,003
– – 1.81% 21
2023
Q4 		$20.3M Buy
+1,895,003
New +$19.3M 1.77% 21

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Commodore Capital's ABVX Position: Q1 2025 in Review

Commodore Capital sold out of Abivax (ABVX) in Q1 2025, closing a stake of 1,284,110 shares — an estimated $9.4M sold.

Commodore Capital first reported a position in ABVX in Q4 2023 and held it in 5 quarters. The position peaked at $27.1M in Q1 2024. 46 funds tracked by Wall St. Rank hold ABVX as of Q1 2025.

  • Commodore Capital reported no remaining Abivax position as of Q1 2025 after selling out during the quarter.
  • Commodore Capital sold 1,284,110 Abivax shares in Q1 2025, an estimated $9.4M.
  • Commodore Capital first reported a position in Abivax in Q4 2023 and held it in 5 quarters.
  • Commodore Capital's Abivax position peaked at $27.1M in Q1 2024.
  • 46 funds tracked by Wall St. Rank held Abivax as of Q1 2025.

Based on Commodore Capital's 13F filing for Q1 2025, filed 15 May 2025.